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Abstract
Background: Metabolic syndrome (MetS) is a major risk factor for cardiovascular disease and diabetes. Previous
studies in obese children demonstrating a positive association between serum uric acid (sUA) and components of
MetS are confounded by lack of uniformity in age and pubertal status of children. Therefore, we have examined the
role of sUA in MetS and its components in pre-pubertal children (Tanner Stage I, age ≤ 9 years).
Methods: Pre-pubertal obese children (32 boys, 27 girls, age 6–9 years) were recruited from Nuevo Leon, Mexico.
For comparison, an equal number of children with normal body mass index (BMI) in the same age range (22 Boys,
39 girls, age 6–9 years) were also recruited from the same community. Presence of MetS and its components was
defined according to the criteria of International Diabetes Federation. Fasting blood was analyzed for lipids, glucose,
insulin, and uric acid.
Results: Among the obese children, sUA was positively associated with insulin resistance and hypertriglyceridemia
and negatively associated with high density lipoprotein-cholesterol (HDLc). Subjects were three times more likely to
have a MetS diagnosis per one unit (md/dL) difference in sUA. Of the 59 obese pre-pubertal children, 20 were
classified as having MetS defined by the presence of abdominal obesity and two or more of other components
described under methods. Of these, 57.1% (20/61) had sUA between 5.1 and 7.1 mg/dl.
Conclusions: The findings of this study clearly indicate a positive relationship between uric acid and MetS and its
components in pre-pubertal obese children with Tanner stage I and ≤9 years of age.
Background
There has been a precipitous rise in the prevalence and
magnitude of childhood obesity over the last few decades
[1]. Unfortunately, it is difficult to determine the rate of
prevalence of metabolic syndrome (MetS) in obese chil-
dren due to complexity of definition, and differences such
as ethnicity, gender and sexual maturity [2]. However,
most studies support the notion that the prevalence of
MetS is high among obese children, and it increases with
degree of obesity [2].
Similar to adult population, there have been scores of
epidemiologic and observational studies examining the
role of serum uric acid (sUA) in MetS in children [3–11].
While in general results of these studies support a direct
relationship between sUA and MetS, the data for analyses
were pooled from pre-, peri- and post-pubertal children
without any control for differences in their sexual maturity
* Correspondence: CPrasad@mail.twu.edu
1TWU-UANL Consortium to Promote Research in Obesity and Obesity-related
Diseases, Monterrey, Mexico
4Department of Nutrition and Food Sciences, Texas Woman’s University, PO
Box 425888, Denton, TX 762014-5888, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Perez et al. BMC Obesity  (2017) 4:25 
DOI 10.1186/s40608-017-0160-6
[3–11]. While the above studies [3–11] support the con-
clusion that the odds ratio of having metS or one or more
its components is associated with sUA, seven of the stud-
ies [3, 4, 6, 7, 9–11] include data from pre-pubertal, post-
pubrtal and post-pubertal children ranging in age between
4 and 18 years making it difficult to assess the role of sUA
in MetS in just pre-pubertal children. The remaining two
studies [5, 8] included peri-pubertal children ranging in
age between 10 and 13 years.
Since sex steroids are known to control uricemia as
well as sexual maturity [12–15], the lack of regard for
sexual maturity in subject selection in these studies re-
quires a re-examination of the relationship. Therefore, in
the present study, we have examined the role of sUA in
MetS and its components in obese pre-pubertal (Tanner
stage I) elementary school children from Mexico and
compared it with sexual maturity matched normal body
mass index (BMI) children in the same age range.
Methods
Study population
In this cross-sectional study, pre-pubertal children were
recruited through a summer health camp for childhood
obesity prevention at Universidad Autónoma de Nuevo
León [16]. For comparison, children with normal BMI
were also recruited from the same community. The
study subjects were from elementary schools in metro-
politan area of Monterrey City and rural municipalities
of Nuevo León, México. The summer camps are orga-
nized annually for obese children who come from low-
income families living in poverty or extreme poverty and
qualify for medical care through the public health system
of México. The same socio-economic measures were ap-
plied to select the children with normal BMI.
Subject selection
The study was approved by the Research Ethical Com-
mittee of the Public Health and Nutrition School at Uni-
versidad Autónoma de Nuevo León, which is registered
with the State Research Ethical Committee in concord-
ance with the Health General Law of Mexico. All the
children and their parents signed a letter of agreement
and consent form.
The major goal of this study was to examine the asso-
ciation between sUA with MetS and its components in
pre-pubertal children. Both sUA and the onset of pu-
berty are affected by gender, age and adiposity [17].
Therefore, it was important that children selected for
this study be not only comparable in age, but are also
pre-pubertal. To this end, a pediatrician screened 200
consecutive obese children in the age group of 6–9 years
for sexual maturity (Tanner Stages of puberty). Of these,
59 obese children were classified as Tanner Stage I
(Table 1). A similar screening of normal BMI children
yielded 61 children belonging to Tanner Stage I [16].
Anthropometric and blood pressure measurement
Weight was measured using digital scales (TanitaBC-
533) while subjects were minimally clothed and without
shoes, recorded to the nearest 100 g. Height was mea-
sured to the nearest 1 cm using a non-elastic tape meter
while subjects were in a barefoot standing position, with
their shoulders in a normal position. BMI was calculated
as weight in kilograms divided by the square of height in
meters. Presence of obesity was determined by BMI-for-
age using WHO Reference [18]. Blood pressure (BP) was
measured twice in the right arm of subjects who had
been resting for at least 10 min in a seated position
using a mercury sphygmomanometer.
Metabolic syndrome and its components
Presence of MetS was determined using the definition of
the International Diabetes Federation (IDF) [19]. Accord-
ing to the IDF definition, someone has the metabolic
syndrome if he or she has central adiposity (waist circum-
ference (WC) ≥ 90th percentile) plus two or more of the
following four factors [19]: a) systolic blood pres-
sure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg,
b) fasting triglycerides (TG) ≥150 mg/dL, c) high density
lipoprotein (HDLc) < 40 mg/dL and d) fasting glucose
≥100 mg/dL).
Biochemical measurements
Blood was collected between 07:30 and 08:00 AM from
the antecubital vein after an 8–12 h overnight fast and
Table 1 Characteristics of the study population
Variables Normal
(n = 61)
Obese
(n = 59)
p-value
Age, years 7.3 ± 1.1 8.0 ± 1.0 0.001a
Tanner Stage I I
Body Mass Index 16.2 ± 1.2 26.2 ± 4.4 0.000a
Waist circumference, cm 55.8 ± 3.9 83.8 ± 11.0 0.000b
Systolic blood pressure, mmHg 83.0 ± 8.9 94.1 ± 10.9 0.000a
Diastolic blood pressure, mmHg 59.6 ± 7.1 63.5 ± 9.6 0.056a
Fasting glucose, mg/dL 80.6 ± 6.6 80.2 ± 6.7 0.741b
Fasting Insulin, UI/mL 8.1 ± 3.2 26.8 ± 20.1 0.000 a
HOMA 1.6 ± 0.7 5.3 ± 4.0 0.000a
Triglycerides, mg/dL 104.5 ± 31.1 155.4 ± 88.9 0.001a
Total cholesterol, mg/dL 160.7 ± 25.3 163.6 ± 34.0 0.598b
LDL-C, mg/dL 87.3 ± 22.4 93.8 ± 28.5 0.165b
HDL-C, mg/dL 52.9 ± 13.4 39.0 ± 8.2 0.000a
Uric Acid, mg/dL 3.4 ± 0.6 4.4 ± 0.9 0.000b
All data except Tanner Stage are presented as mean ± SD. aThe Mann-Whitney
U test. bt-Test for independent samples
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centrifuged within 2 h for separation of serum. Ali-
quoted samples were stored at −20 °C until analyses.
Serum Total cholesterol and TG were determined enzy-
matically by an autoanalyzer using commercial kits avail-
able (Beckman Coulter, Inc., CA, USA). Serum HDLc
was measured similarly after precipitation with magne-
sium phosphotungstate. Serum low density lipoprotein-
cholesterol (LDLc) was calculated using Friedwald’s
formula [20] as shown below.
LDL−chol½  ¼ Total chol½ − HDL−chol½ − TG½ =5ð Þ
where all concentrations are given in mg=dL
Fasting plasma glucose was measured via colorimetric
assay and insulin levels were determined using radio-
immunoassay. Serum uric acid levels were determined col-
orimetrically using Uricase. Assays were done in triplicate
and were performed at the General and Endocrinology La-
boratories of the Hospital Universitario Dr. José Eleuterio
González. The laboratory routinely monitors both inter-
and intra-assay coefficients of variation for all assays with a
goal to keep it at 5% or below. For example, in our insulin
assay, inter- and intra-assay coefficient of variation was 2.9–
3.8% and 2.5–4.4%, respectively. Insulin-resistance (IR) was
evaluated with the aid of homeostasis model assessment
(HOMA) and defined as HOMA >2.7 (HOMA-IR) [21].
Statistical analyses
Continuous data is presented as means ± SD. A post-hoc
power analysis was performed to determine the statistical
power to detect significant differences for the main com-
parison. Using a moderate effect size of 0.50, an alpha of
0.05, and a combined sample size n = 120; we calculated a
power of 0.845, that meets the minimum suggested power
for a study [22]. Data were analyzed using multivariate stat-
istical software SPSS (version 22). Differences in the compo-
nents of the MetS, age, Tanner stage, fasting insulin and
HOMA among the different groups were analyzed by de-
scriptive and exploratory statistical analyses. Mann-Whitney
U test was applied to examine statistical significance among
the variables such as age, BMI, systolic pressure, diastolic
pressure, fasting insulin, HOMA, triglycerides and HDLc. A
t-test for independent samples was used to examine differ-
ences in means between the obesity group and normal BMI
control group based on identified factors: glucose, waist cir-
cumference, total cholesterol, and LDLc. To determine the
statistical association between the presence of Met S and
sUA, a binary logistic regression equation was utilized. The
predictive variables were age, (continuous), the concentra-
tion of sUA (continuous), gender (dichotomous) and BMI
(continuous). The scatter-plots were made with their re-
spective linear correlation and equation of simple linear re-
gression to examine the relationship between concentration
of sUA to fasting insulin, HOMA, HDLc, and triglycerides.
Results
Distribution of sUA in obese and normal BMI pre-
pubertal children in the age group 6–9 years is shown in
Fig. 1. There were more children with high sUA in the
obese group (43/59, Range: 2.5–7.5 mg/ml; 70% with sUA
≥4.0 mg/ml) than in the normal BMI group (9/61, Range:
2.2–4.8 mg/ml; 15% with sUA ≥4.0 mg/dl) (p = 0.001).
The baseline characteristics of children in the obese and
normal BMI groups are shown in Table 1. Both normal
BMI and obese groups were matched closely in sample
size and age. Children in the obese group were only
8 months older, however, children in both groups were
under 9 years of age. Furthermore, all obese and normal
BMI children were pre-pubertal with Tanner stage I. Chil-
dren in the obese group had significantly greater waist cir-
cumference (p = 0.001), increased systolic blood pressure
(p = 0.001), elevated fasting insulin (p = 0.001), insulin re-
sistance measured by HOMA (p = 0.001), higher TG
(p = 0.002), higher sUA (p = 0.001), and lower HDLc
(p = 0.001) compared to the normal BMI group. These
data clearly show the presence of components of MetS in
pre-pubertal obese children.
Of the 59 obese pre-pubertal children, 32 were boys and
27 were girls. We next analyzed gender differences be-
tween the prevalence of the components of MetS in obese
children. Results presented in Table 2 show that obese
girls were at a higher risk for insulin resistance than obese
boys as shown by increased fasting insulin (p = 0.003) and
HOMA values (p = 0.00). Also, obese girls had signifi-
cantly lower HDLc than obese boys (p = 0.014). Interest-
ingly, however, there was no difference in the levels of
sUA between obese boys and obese girls (p = 0.543).
We used a multivariate analysis to establish the associ-
ation between sUA and components of MetS after adjust-
ing for gender, age, and BMI (Table 3). The results show
that with one unit difference (1 unit = 1 mg/dL) in sUA,
there were 3.9 times more likely to have a MetS diagnosis
as defined by IDF. Similarly, higher sUA levels are signifi-
cantly associated with high waist circumference, high TG
and low HDLc. Of the 59 obese pre-pubertal children, 20
were classified as having MetS defined by the presence of
abdominal obesity and two or more of other components
described under methods. Of these, 57.1% (20/61) had
sUA between 5.1 and 7.1 mg/dl.
Data presented in Fig. 2 show the positive relationship
(p < 0.05) between elevated sUA and measures of insulin
sensitivity (insulin in Panel A and HOMA in Panel B).
Similarly, hyperuricemia was positively associated
(p < 0.05) with hypertriglyceridemia in Panel C and and
negatively associated with HDLc in Panel D.
Discussion
The conclusion of the earlier studies examining relationship
between sUA and higher odds ratio for MetS or its
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components in children are similar to our observation [3–
11]. However, the conclusions reached in these studies were
confounded because they did not control for race/ethnicity,
gender, age and stages of sexual maturity in subject selec-
tion [3–11]. For example, Gill-Gampos et al. reported a
positive association between the features of insulin resist-
ance and hyperuricemia in prepubertal children ranging in
ages between 6 and 12 years [23]. Similar to our results,
Viazzi et al. reported that hyperuricemia was associated
with increased blood pressure in children ranging in age be-
tween 6 and 18 years [24]. Multiple other studies have ex-
amined such associations and have suggested a role for
hyperuricemia in MetS and its components in younger
population [3–11]. The data presented in Table 3 are the
first to show an association between risks for known com-
ponents of MetS and sUA in obese prepubertal children
(age: 6–9 years and Tanner Stage I) in Monterrey, Mexico.
These data offer the possibility of use of sUA as a predictor
of MetS in pre-pubertal children.
The results of these studies offer only a predictive
relationship between sUA and MetS in obesity. The
cause and effect relationship between sUA and obes-
ity can only be speculated at this time. Approxi-
mately two thirds of total body uric acid is produced
endogenously, while the remaining one third results
from metabolism of dietary purines [25]. Hyperurice-
mia may occur because of increased production
(overproducers), decreased excretion (underexcre-
tors), or a combination of these two mechanisms. In
a recent study, Tsushima et al. [26], demonstrated el-
evated uric acid secretion from whole adipose tissue
in obese vs. lean mice, and from 3 T3-L1 adipocytes
under hypoxia suggesting that purine catabolism to
uric acid in adipose tissue could be enhanced in
obesity. In support of decreased excretion, Yamashita
et al. [27] reported marked reduction of renal uric
acid excretion in obese subjects and its improvement
by a low-calorie diet. Matsuura et al. [28] observed
that while all obese subjects had higher sUA than
normal-weight control subjects, subjects with visceral
obesity were linked more closely to overproduction
and under excretion of uric acid. Taken together,
these studies support the thesis that both uric acid
production and excretion play an active role in de-
termining the state of sUA. However, since these
foregoing observations came from animal, cell cul-
ture and adult human studies, their relevance to pre-
pubertal children needs to be examined.
Fig. 1 Distribution of the serum uric acid in obese and normal BMI pre-pubertal children (n = 120) aged 6–9 years. Frequency = Number of children
Table 2 Characteristics of the obese group by gender
Obese
Variables Boys
(n = 32)
Girls
(n = 27)
p-value
Age, years 7.8 ± 1.0 8.2 ± 0.9 0.132a
Tanner Stage I I
Body Mass Index 26.3 ± 4.8 26.2 ± 3.9 0.999a
Waist circumference, cm 84.4 ± 12.2 83.0 ± 9.5 0.646b
Systolic blood pressure, mmHg 95.0 ± 13.1 92.9 ± 7.7 0.734a
Diastolic blood pressure, mmHg 65.6 ± 11.3 61.1 ± 6.4 0.122a
Fasting glucose, mg/dL 80.4 ± 6.4 79.9 ± 7.2 0.761b
Fasting Insulin, UI/mL 20.5 ± 13.5 34.2 ± 24.1 0.002a
HOMA 4.1 ± 2.7 6.7 ± 4.7 0.003a
Triglyceride, mg/dl 144.3 ± 88.7 168.4 ± 89.0 0.191a
Total cholesterol, mg/dl 167.5 ± 32.9 158.9 ± 35.4 0.337b
LDL-C, mg/dL 98.0 ± 29.4 88.9 ± 27.2 0.226b
HDL-C, mg/dL 41.3 ± 8.5 36.2 ± 7.0 0.017b
Uric Acid, mg/dL 4.5 ± 1.0 4.3 ± 0.7 0.430b
aThe Mann-Whitney U test. bt-Test for independent samples
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Table 3 Adjusted odds ratios (95% CI)* for association 1 between the MetS and 2 its components with sUA
Variables Odds ratio 95% CI p-value
Metabolic syndrome n = 59 Age (yr) 0.620 [0.302, 1.273] 0.193
Uric Acid (mg/dL) 3.942 [1.589, 9.775] 0.003
Gender 0.208 [0.048, 0.901] 0.208
BMI (kg/m2) 1.113 [0.949, 1.304] 0.187
Abdominal obesity (waist
circumference > 90th percentile)
n = 53
Age (yr) 0.677 [0.328, 1.397] 0.291
Uric Acid (mg/dL) 3.854 [1.518, 9.787] 0.005
Gender 0.212 [0.048, 0.930] 0.040
BMI (kg/m2) 1.074 [0.907, 1.271] 0.410
High triglyceride (≥150 mg/dL)
n = 25
Age (yr) 0.504 [0.124, 2.048] 0.338
Uric Acid (mg/dL) 2.267 [0.560, 9.180] 0.251
Gender 0.474 [0.029, 7.801] 0.601
BMI (kg/m2) 1.406 [0.835, 2.369] 0.200
Low HDL-C (<40 mg/dL)
n = 33
Age (yr) 0.210 [0.031, 1.008] 0.110
Uric Acid (mg/dL) 65.751 [2.509,1723.076] 0.012
Gender 0.040 [0.001, 2.003] 0.107
BMI (kg/m2) 1.559 [0.764, 3.182] 0.223
All the models were adjusted by gender (men compared with women), age (continuous), body mass index (continuous) and concentration of uric
acid (continuous)
*The unit of the exposures for the OR estimate was the presence or absence of Metabolic
Syndrome or its components- abdominal obesity, high triglycerides and low HDL-C
Fig. 2 Association between serum serum uric acid concentration and fasting insulin, HOMA, trigycerides and HDLc. a Insulin (y = − 4.761 + 5.631×;
r = 0.287; p-value = 0.001, two-tailed analysis; n = 119). b HOMA (y = − 0.746 + 1.070×; r = 0.300; p-value = 0.002, two-tailed analysis; n = 119). c
Triglycerides (y = 6.933 + 31.273×; r = 0.403; p-value = 0.000, two-tailed analysis; n = 119). d HDLc (y = 63.735–4.507×; r = − 0.313; p-value = 0.001,
two-tailed analysis; n = 119)
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Limitations of this study
While the strength of this study lies in our demonstra-
tion of an association between higher sUA and higher
odds ratio for components of MetS, this is a cross-
sectional study and causality cannot be inferred. The re-
lationship between pediatric obesity and MetS is com-
plex because the risk for sequelae of both obesity and
MetS vary among individuals based on ethnicity, socio-
economic status and associated lifestyle practices [29].
Conclusions
Compared with normal weight children, obese children
are more likely to experience hyperuricemia. Also there
was a positive relationship between sUA and MetS and
its components in pre-pubertal obese children with Tan-
ner stage I and ≤9 years of age. Further studies are
needed to understand role of uric acid in eliciting MetS
and its components these children.
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